Rotavirus Disease in Uzbekistan: Cost-Effectiveness of a New Vaccine
Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.
Author: Isakbaeva E, Musabaevc E, Antil L, et al.
» Download file (Russian)
161 KB PDF
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Isakbaeva E, Musabaev E, Antil L, et al. Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine. Vaccine. 2007;25(2):373-380.
Resource types: Peer-reviewed journal
Regions: Eastern Europe